Concepts (248)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Adenoma, Oxyphilic
- Adipose Tissue
- Adiposity
- Administration, Oral
- Adolescent
- Adrenal Cortex Neoplasms
- Adult
- Aged
- Aged, 80 and over
- Aging
- Albumins
- Alzheimer Disease
- Amyloid beta-Peptides
- Angiotensin Receptor Antagonists
- Angiotensin-Converting Enzyme Inhibitors
- Animals
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Anticholesteremic Agents
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Apolipoprotein B-100
- Apolipoproteins B
- Atherosclerosis
- Bariatric Surgery
- Benzhydryl Compounds
- Betacoronavirus
- Bile
- Biomarkers
- Biomarkers, Tumor
- Biopsy
- Birth Weight
- Blood Glucose
- Blood Glucose Self-Monitoring
- Body Mass Index
- Body Weight
- Cardiomyopathy, Hypertrophic
- Cardiotoxicity
- Cardiovascular Diseases
- Cell Differentiation
- Cells, Cultured
- Child Development
- Child, Preschool
- Cholangiocarcinoma
- Cholestasis
- Cholesterol
- Cholesterol, HDL
- Cholesterol, LDL
- Clinical Decision-Making
- Clinical Protocols
- Clinical Trials as Topic
- Clinical Trials, Phase III as Topic
- Cognition
- Congresses as Topic
- Consensus
- Coronary Disease
- Coronavirus Infections
- Cross-Sectional Studies
- Diabetes Complications
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetes, Gestational
- Diabetic Cardiomyopathies
- Diabetic Ketoacidosis
- Diagnostic Errors
- Diet, High-Fat
- Dipeptidyl-Peptidase IV Inhibitors
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Double-Blind Method
- Down-Regulation
- Drug Administration Schedule
- Drug Interactions
- Drug Therapy, Combination
- Dyslipidemias
- Echocardiography
- Endocrine System Diseases
- Endocrinology
- Enzyme-Linked Immunosorbent Assay
- Europe
- Evidence-Based Medicine
- Ezetimibe
- Fatty Liver
- Fear
- Feces
- Female
- Fibric Acids
- Fluorodeoxyglucose F18
- Follow-Up Studies
- France
- Frontotemporal Lobar Degeneration
- Gastrectomy
- Gastric Bypass
- General Practitioners
- Genetic Predisposition to Disease
- Gestational Age
- Glomerular Filtration Rate
- Glucagon-Like Peptides
- Glucose
- Glucosides
- Glycated Hemoglobin A
- Glycation End Products, Advanced
- Glycosides
- GRB10 Adaptor Protein
- GRB7 Adaptor Protein
- GTP-Binding Protein gamma Subunits
- Health Knowledge, Attitudes, Practice
- Heart
- Hepatobiliary Elimination
- Heredity
- Heterotrimeric GTP-Binding Proteins
- Heterozygote
- HIV Infections
- HIV Protease Inhibitors
- Homozygote
- Hospital Mortality
- Hospitalization
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hypercholesterolemia
- Hyperglycemia
- Hyperlipoproteinemia Type II
- Hyperlipoproteinemia Type V
| - Hypertension
- Hypobetalipoproteinemias
- Hypoglycemia
- Hypoglycemic Agents
- Hypolipidemic Agents
- Immunotherapy
- Incidence
- Infant
- Infant, Newborn
- Infant, Premature
- Inflammation
- Inflammation Mediators
- Infusion Pumps, Implantable
- Injections, Subcutaneous
- Inpatients
- Insulin
- Insulin Glargine
- Insulin Infusion Systems
- Insulin Lispro
- Insulin Resistance
- Intensive Care Units
- Intestinal Elimination
- Intestinal Mucosa
- Intestines
- Ki-67 Antigen
- Laparoscopy
- Learning
- Length of Stay
- Linear Models
- Lipid Metabolism
- Lipodystrophy
- Lipoproteins
- Lipoproteins, LDL
- Liver
- Logistic Models
- Lovastatin
- Lymphocytes
- Magnetic Resonance Imaging
- Magnetic Resonance Spectroscopy
- Male
- Medication Adherence
- Metabolic Diseases
- Metformin
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Mice, Obese
- Middle Aged
- Models, Animal
- Multicenter Studies as Topic
- Mutation
- Myocardium
- Nausea
- Neoplasms
- Non-alcoholic Fatty Liver Disease
- Obesity
- Obesity, Morbid
- Oocytes
- Pandemics
- Particle Size
- Patient Discharge
- Pedigree
- Peptide Fragments
- Permeability
- Phenotype
- Phosphorylation
- Physicians
- Plasma
- Pneumonia, Viral
- Polyethylene Glycols
- Positron-Emission Tomography
- Practice Patterns, Physicians'
- Predictive Value of Tests
- Pregnancy
- Prevalence
- Prognosis
- Propensity Score
- Proprotein Convertase 9
- Proprotein Convertases
- Prospective Studies
- Protein Kinase Inhibitors
- Protein Structure, Tertiary
- Proteins
- Protein-Tyrosine Kinases
- Radiopharmaceuticals
- Randomized Controlled Trials as Topic
- Receptor Protein-Tyrosine Kinases
- Receptor, Fibroblast Growth Factor, Type 1
- Receptor, Fibroblast Growth Factor, Type 4
- Receptors, Fibroblast Growth Factor
- Receptors, LDL
- Recurrence
- Registries
- Renal Dialysis
- Renal Insufficiency, Chronic
- Research Design
- Respiration, Artificial
- Retrospective Studies
- Risk
- Risk Assessment
- Risk Factors
- Schizophrenia
- Secondary Prevention
- Sensitivity and Specificity
- Serine Proteinase Inhibitors
- Serum Albumin
- Severity of Illness Index
- Sex Characteristics
- Signal Transduction
- Sitagliptin Phosphate
- src Homology Domains
- Surveys and Questionnaires
- tau Proteins
- Thiazolidinediones
- Time Factors
- TOR Serine-Threonine Kinases
- Treatment Outcome
- Triglycerides
- Ventricular Dysfunction, Left
- Ventricular Function
- Weight Loss
- Xenopus
- Xenopus Proteins
- Young Adult
|
Cariou's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(248)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(128)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_